Showing the prevalence of use of individual instruments (shown as the number of previous studies and %) and responses to Delphi survey 1 (shown as the number of responses and %)
| Domain: measure | Prevalence | Clinicians and researchers | Patients (n=7) | |||||
| *n | a | b | c | a | b | c | ||
| Patient rating of condition | ||||||||
| Global Perceived Effect Score | 1 (<1) | 39 | 22 (56) | 28 (72) | 36 (92) | 5 (71) | 6 (86) | 6 (86) |
| GROC | 9 (4) | 39 | 25 (64) | 29 (74) | 34 (87) | 4 (57) | 6 (86) | 6 (86) |
| Patient Satisfaction Scale | 29 (11) | 39 | 20 (51) | 25 (64) | 35 (90) | 5 (71) | 6 (86) | 6 (86) |
| Roles and Maudsley† | 15 (6) | |||||||
| Participation (daily activities, work and sport) | ||||||||
| Return to sport | 5 (2) | 39 | 15 (38) | 25 (64) | 32 (82) | 5 (71) | 5 (71) | 6 (86) |
| Time off work | 16 (6) | 39 | 21 (54) | 31 (79) | 30 (77) | 4 (57) | 4 (57) | 6 (86) |
| Total Elbow Scoring System | 1 (<1) | 39 | 12 (31) | 14 (36) | 21 (54) | 4 (57) | 4 (57) | 5 (71) |
| OSTRC question 1† | 0 | |||||||
| Pain on activity/loading | ||||||||
| Tennis Elbow Functional Scale | 2 (1) | 39 | 11 (28) | 24 (62) | 22 (56) | 6 (86) | 6 (86) | 6 (86) |
| Thomsen Test (VAS pain resisted wrist extension) | 7 (3) | 39 | 14 (36) | 28 (72) | 28 (72) | 5 (71) | 5 (71) | 6 (86) |
| VAS chair pick-up | 2 (1) | 39 | 9 (23) | 20 (51) | 23 (59) | 2 (29) | 6 (86) | 4 (57) |
| VAS pain during activity | 49 (19) | 39 | 31 (79) | 35 (90) | 34 (87) | 4 (57) | 5 (71) | 6 (86) |
| VAS pain during elbow movement | 5 (2) | 39 | 7 (18) | 13 (33) | 27 (69) | 2 (29) | 3 (43) | 6 (86) |
| VAS pain on gripping | 16 (6) | 39 | 28 (72) | 37 (95) | 35 (90) | 5 (71) | 5 (71) | 7 (100) |
| VAS pain at work | 11 (4) | 39 | 15 (38) | 23 (59) | 29 (74) | 3 (43) | 3 (43) | 4 (57) |
| Pain Free Functional Index | 2 (1) | 39 | 7 (18) | 20 (51) | 23 (59) | 3 (43) | 3 (43) | 6 (86) |
| PRTEE†‡ | 78 (30) | 38 | 24 (63) | 30 (79) | 27 (71) | 7 (100) | 7 (100) | 7 (100) |
| Function | ||||||||
| Patient Specific Functional Scale | 1 (<1) | 38 | 11 (29) | 24 (63) | 20 (53) | 5 (71) | 6 (86) | 6 (86) |
| Upper Extremity Functional Scale | 5 (2) | 38 | 17 (45) | 26 (68) | 26 (68) | 4 (57) | 4 (57) | 7 (100) |
| VAS function | 6 (2) | 38 | 17 (45) | 24 (63) | 29 (76) | 2 (29) | 3 (43) | 4 (57) |
| PRTEE†‡ | 78 (30) | |||||||
| Psychological factors | ||||||||
| Hospital Anxiety and Depression Scale | 3 (1) | 38 | 14 (37) | 20 (53) | 19 (50) | 2 (29) | 2 (29) | 6 (86) |
| Tampa Scale of Kinesophobia | 4 (2) | 38 | 15 (39) | 19 (50) | 21 (55) | 5 (71) | 6 (86) | 5 (71) |
| STAI trait† | 0 | |||||||
| Nottingham Health Profile† | 3 (1) | |||||||
| Physical function capacity (eg, strength) | ||||||||
| Grip strength (maximum) | 93 (36) | 38 | 18 (47) | 31 (82) | 26 (68) | 6 (86) | 6 (86) | 7 (100) |
| Pain-free grip strength | 42 (16) | 38 | 25 (66) | 30 (79) | 27 (71) | 6 (86) | 6 (86) | 7 (100) |
| Elbow ROM | 6 (2) | 38 | 4 (11) | 12 (32) | 25 (66) | 3 (43) | 2 (29) | 7 (100) |
| Disability | ||||||||
| Andrews-Carson | 2 (1) | 38 | 0 (0) | 3 (8) | 10 (26) | 1 (14) | 1 (14) | 3 (43) |
| ASES score | 5 (2) | 38 | 4 (11) | 17 (45) | 13 (34) | 3 (43) | 3 (43) | 5 (71) |
| Broberg and Morrey Rating System | 1 (<1) | 38 | 1 (3) | 8 (21) | 10 (26) | 2 (29) | 3 (43) | 5 (71) |
| DASH | 77 (30) | 38 | 15 (39) | 26 (68) | 17 (45) | 4 (57) | 4 (57) | 5 (71) |
| HAND10 | 1 (<1) | 38 | 3 (8) | 17 (45) | 23 (61) | 4 (57) | 4 (57) | 6 (86) |
| Japanese Orthopaedic Association Elbow Score | 2 (1) | 38 | 4 (11) | 17 (45) | 16 (42) | 0 (0) | 0 (0) | 4 (57) |
| Laitinen Questionnaire | 1 (<1) | 38 | 5 (13) | 14 (37) | 15 (39) | 1 (14) | 1 (14) | 4 (57) |
| Liverpool Elbow Score | 1 (<1) | 38 | 1 (3) | 13 (34) | 13 (34) | 2 (29) | 3 (43) | 3 (43) |
| Mayo Elbow Performance Score | 30 (12) | 38 | 3 (8) | 12 (32) | 15 (39) | 0 (0) | 0 (0) | 2 (29) |
| Nirschl | 18 (7) | 38 | 7 (18) | 22 (58) | 21 (55) | 4 (57) | 4 (57) | 4 (57) |
| Nottingham Health Profile | 3 (1) | 38 | 1 (3) | 6 (16) | 12 (32) | 0 (0) | 0 (0) | 0 (0) |
| Oxford Elbow Score | 4 (2) | 38 | 9 (24) | 20 (53) | 21 (55) | 4 (57) | 5 (71) | 6 (86) |
| Patient-Rated Wrist Evaluation Questionnaire | 1 (<1) | 38 | 5 (13) | 17 (45) | 19 (50) | 4 (57) | 4 (57) | 6 (86) |
| PRTEE†‡ | 78 (30) | 37 | 27 (73) | 34 (92) | 32 (86) | 6 (86) | 6 (86) | 6 (86) |
| Quick DASH | 37 (14) | 38 | 27 (71) | 29 (76) | 31 (82) | 7 (100) | 7 (100) | 7 (100) |
| Total Elbow Scoring System | 1 (<1) | 38 | 4 (11) | 14 (37) | 20 (53) | 2 (29) | 2 (29) | 4 (57) |
| Roles and Maudsley | 15 (6) | 38 | 2 (5) | 11 (29) | 22 (58) | 1 (14) | 2 (29) | 4 (57) |
| Quality of life | ||||||||
| EQ5D | 9 (4) | 37 | 19 (51) | 22 (59) | 25 (68) | 4 (57) | 4 (57) | 6 (86) |
| SF-36 | 13 (5) | 37 | 6 (16) | 23 (62) | 9 (24) | 1 (14) | 5 (71) | 2 (29) |
| SF-12 | 4 (2) | 37 | 15 (41) | 25 (68) | 25 (68) | 3 (43) | 5 (71) | 4 (57) |
| Nottingham Health Profile† | 3 (1) | |||||||
| WHOQol BREF† | 0 | |||||||
| SMFA† | 0 | |||||||
| Pain over a specified timeframe | ||||||||
| VAS night pain | 9 (4) | 37 | 14 (38) | 26 (70) | 32 (86) | 2 (29) | 4 (57) | 6 (86) |
| VAS pain defined time period | 22 (9) | 37 | 25 (68) | 30 (81) | 29 (78) | 2 (29) | 3 (43) | 5 (71) |
| VAS pain at rest | 52 (20) | 37 | 21 (57) | 25 (68) | 31 (84) | 1 (14) | 2 (29) | 5 (71) |
| Tennis Elbow Functional Scale | 2 (1) | 37 | 8 (22) | 22 (59) | 21 (57) | 6 (86) | 6 (86) | 6 (86) |
| Measures from review not mapped | ||||||||
| Analgesic use | 2 (1) | 37 | 16 (43) | 1 (14) | ||||
| Canadian Occupational Performance Measure | 1 (<1) | 37 | 2 (5) | 1 (14) | ||||
| Cold Pain Threshold | 5 (2) | 37 | 3 (8) | 1 (14) | ||||
| EMG | 5 (2) | 37 | 0 (0) | 2 (29) | ||||
| Gothenburg QoL Instrument | 1 (<1) | 37 | 0 (0) | 0 (0) | ||||
| MRI appearance | 5 (2) | 37 | 3 (8) | 1 (14) | ||||
| ORI-TETS | 3 (1) | 37 | 1 (3) | 1 (14) | ||||
| Placzek Score | 1 (<1) | 37 | 4 (11) | 2 (29) | ||||
| Pressure Pain Threshold | 24 (9) | 37 | 7 (19) | 1 (14) | ||||
| US appearance | 13 (5) | 37 | 4 (11) | 1 (14) | ||||
| UoP-PFQ | 2 (1) | 37 | 1 (3) | 1 (14) | ||||
| VAS pain on palpation | 12 (5) | 37 | 4 (11) | 2 (29) | ||||
| VAS pain overall | 101 (39) | 37 | 9 (24) | 2 (29) | ||||
| WL-26 | 1 (<1) | 37 | 2 (5) | 4 (57) | ||||
a: this measure should be in the core outcome set for lateral elbow tendinopathy.
b: this measure has content and face validity.
c: the measure is clinically feasible.
Green (yes responses: ≥70%) and amber (unsure responses: 30%–69%) were progressed to subsequent stages of the Delphi, whereas red (<30%) were removed.
*2 participants partially completed the first survey and their data was included herein.
†Outcome measures suggested by participants, noting PRTEE was not new to the list.
‡Removal of one participant’s response who was designer of the measure.
ASES, American Shoulder and Elbow Surgeons; DASH, Disability of Arm, Shoulder and Hand Questionnaire; EMG, electromyography; GROC, Global Rating of Change; ORI-TETS, Orthopaedic Research Institute-Tennis Elbow Testing System; OSTRC, Oslo Sport Trauma Research Centre Questionnaire; PRTEE, Patient Rated Tennis Elbow Evaluation; QoL, quality of life; ROM, range of movement; SF-12, 12-item Short Form Health Survey; SF-36, 36-item Short Form Health Survey; SMFA, Short Musculoskeletal Function Assessment; STAI, State–Trait Anxiety Inventory; UoP-PFQ, University of Peloponnese Pain, Functionality and Quality of Life Questionnaire; US, ultrasound; VAS, Visual Analogue Scale; WHOQol BREF, WHO Quality of Life Abbreviated Questionnaire; WL-26, Work Limitation 26-item Questionnaire.